全球即时 (POC) 诊断测试市场：2024 年

体外诊断 (IVD) 产业依靠医院和参考实验室使用的实验室分析设备来创造收入。 然而，即时护理 (POC) 领域被视为关键成长领域。 护理点是指在就诊时或在患者家中提供有意义的结果的测试。

诊断在促进健康、改善患者与照护者的接触、支持药物选择和管理、促进家庭护理、有效的流行病管理等方面的作用是即时护理 (POC) 解决方案成功的关键。 由于医院内外对准确、快速检测的需求不断增加，全球 POC 检测市场在过去二十年中经历了显着增长。 智慧型手机、生物感测器、晶片实验室和穿戴式装置的技术进步正在影响 POC 领域，旨在在护理点提供快速诊断。

本报告调查了全球即时护理 (POC) 诊断测试市场，并总结了市场概况、按细分市场划分的市场趋势、进入市场的公司概况以及产品概述。

目录

第 1 章执行摘要

• 简介
• 范围与研究方法
• 市场规模与成长
• 影响市场的趋势
• 竞争前景
• 市场结论

第 2 章简介与概述

• 即时诊断测试
• 行业法规
• CLIA 凭证类型
• 推动 POC 产业发展的因素
• 以病人为中心的促进者
• 医疗/保健相关司机
• 技术驱动因素
• 经济驱动因素
• 其他司机
• POC产业面临的挑战
• POC 测试的类型
• 血
• 尿液
• 唾液
• 头髮
• 光学技术
• 呼吸
• 透过 POC 诊断测试评估的症状
• 癌症
• 循环系统疾病
• 糖尿病
• 滥用药物
• 传染病
• 骨质疏鬆症
• 怀孕和生育

第3章 POC 血糖值测试

第4章POC血液和电解质检测市场

第5章 POC快速凝固

第 6 章 POC 快速心臟标记

第 7 章 POC 药物滥用

第 8 章 POC 妊娠与不孕症检测

第9章POC大肠直肠癌筛检/粪便隐血检验

第10章 POC传染病检测

第11章POC血脂测试

第12章POC癌症肿瘤标记检测

第13章 POC 尿液检查

第14章其他POC测试

第 15 章问题与趋势

第16章全球POC测试市场整体及竞争分析

• 市场概览
• 依产品类别进行市场分析
• 依子类别进行市场分析
• POC 自测试
• POC专业测试
• 依最终用途进行 POC 测试
• 依设备技术划分的市场
• 国家市场分析
• 美国
• 欧洲
• 日本
• 其他领域
• 竞争对手分析

第17章公司简介

• Step Detect Associates, LLC
• Abbott Laboratories
• Abingdon Health Ltd.
• Access Bio, Inc.
• AccuBioTech Co, Ltd.
• ACON Laboratories, Inc
• Aerscher Diagnostics, LLC
• Alfa Scientific Designs, Inc
• American Bio Medica Corporation
• ARKRAY, Inc.
• Artron Laboratories, Inc
• Ascensia Diabetes Care Holdings AG
• Atlas Link Biotech Co., Ltd
• Autobio Diagnostics Co., Ltd
• Beckman Coulter, Inc
• Becton Dickinson (BD)
• Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
• Bhat Bio-Tech India Private Ltd. (BBI)
• binx health
• bioLytical Laboratories
• BioMedomics, Inc.
• Biomeme, Inc.
• Biomerica, Inc.
• bioMerieux SA
• Bio-Rad Laboratories Inc.
• Biosynex SA
• Biotron Diagnostics, Inc.
• Boditech Med Inc.
• Boson Biotech Co. Ltd.
• BTNX Inc.
• Cepheid, Inc.
• Chembio Diagnostics Systems, Inc.
• Church & Dwight Co. Inc.
• Clarity Diagnostics, LLC
• Confirm Biosciences
• CTK Biotech, Inc.
• Cue Health
• Danaher Corporation
• Dexcom, Inc.
• DIALAB GmbH
• DiaSys Diagnostic Systems GmbH（Mindray）
• Diazyme Laboratories, Inc.
• DNA Electronics Ltd.
• Dr. Fooke-Achterrath Laboratorien GmbH
• DxGen Corp.
• Eiken Chemical Co. Ltd.
• EKF Diagnostics Holdings plc
• ELITechGroup S.A.S.
• Eurobio Scientific
• Everlywell
• Exact Sciences
• EY Laboratories
• First Check Diagnostics LLC
• GenBio
• Genedrive plc
• GeTein Biotech Inc.
• Helena Laboratories
• Hemosure, Inc. (W.H.P.M)
• HORIBA, Ltd.
• Immune IQ
• Immunosciences Lab, Inc.
• Immunostics, Inc.
• JAL Innovation PTE LTD.
• Jant Pharmacal Corporation
• Mitra & Co Pvt. Ltd.
• Kypha
• LamdaGen Corporation
• LifeScan, Inc.
• LifeSign, LLC
• LightDeck Diagnostics
• LumiraDx UK Limited
• Macherey-Nagel GmbH & Co. KG
• Medix Biochemica
• MedMira, Inc.
• Medtronic, Inc.
• Menarini Diagnostics srl.
• Meridian Bioscience, Inc.
• MiCo BioMed
• Nano-Ditech Corporation
• Nexus Dx Inc.
• NG Biotech
• Noble Medical, Inc.
• Nova Biomedical Corp.
• Oasis Diagnostics Corporation
• Operon S.A
• OPKO Health, Inc.
• OraSure Technologies, Inc.
• PixCell Medical Technologies
• Polymedco, Inc.
• Polymer Technologies, Inc. (PTS Diagnostics)
• Preventis GmbH
• Princeton Biomeditech Corporation
• QuantuMDx Group Limited
• QuidelOrtho Corporation
• Radiometer Medical A/S
• Randox Laboratories Limited
• Response Biomedical Corp.
• Reszon Diagnostics International Sdn. Bhd.
• Rheonix, Inc.
• Roche Diagnostic Corporation
• Savyon Diagnostics
• Sekisui Diagnostics LLC
• Siemens Healthineers GmbH
• Sysmex Corporation
• TECHLAB, Inc.
• Trinity Biotech PLC
• Trividia Health
• Tulip Diagnostics Ltd. (Tulip Group)
• VedaLab
• Werfen

NOW IN ELEVEN EDITIONS - "The Worldwide Market for Point-of-Care (POC) Diagnostic Tests" forecasts the POC market through 2028.

Lab-based analyzers in hospitals and reference labs are the cornerstone of revenues in the in vitro diagnostics (IVD) industry. However, the point-of-care (POC) segment is seen as a key growth area. Point-of-care refers to tests that can provide meaningful results during a provider visit or in the patient's home.

Over the past two decades, Kalorama Information has observed that POC tests present significant opportunities for expansion. This rich history analyzing the market is at the forefront of "The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 2024", the eleventh edition in Kalorama's POC report series.

The role of diagnostics in promoting wellness, improving patient-provider encounters, aiding in drug selection and stewardship, facilitating home or nursing home care, and ensuring effective pandemic management relies heavily on the success of point-of-care solutions. The global POC testing market has experienced significant growth in the last two decades due to the increasing demand for accurate and rapid testing, both within and outside hospital settings. Technological advancements in smartphones, biosensors, lab-on-a-chip, and wearable devices have influenced the POC landscape, aiming to provide expedited diagnosis at the point-of-care.

As a result, point-of-care diagnostics can command higher pricing and experience larger revenue growth compared to lab-based tests. The tests covered in "The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 2024" tend to grow at higher rates than the overall IVD market.

Enhanced Segmentation - Many Reports in One

The report delves into various areas of POC diagnostics, including:

Each area is thoroughly analyzed, providing market sizing and forecasts.

Venue Market Analysis

POC tests are conducted in various settings, including hospital departments (emergency, operating rooms, intensive care units), physicians' offices, hospital clinics, retail clinics, pharmacies, homes (self-testing or by caregivers), and nursing homes.

POC testing may be performed by laboratory personnel, but often it is performed by non-laboratory personnel such as physicians, nurses, assistants in medical offices, emergency medical technicians (EMTs), medics, pharmacists, and the patients themselves (self-testing). Some POC tests are manual tests, often performed with technologies based on dipsticks or strips, lateral flow cassettes, or other manual tests. There are also many small, portable instruments that have been developed for use in POC settings. With the advances in miniaturization and microfluidics that have occurred in recent years, a growing number of small, handheld devices are reaching the POC market for a range of different testing applications.

Regional Coverage

POC is an international market and Kalorama reflects this with regional coverage. Analysis is anchored by:

Other countries and regions discussed in the report include:

Corporate Profiles

"The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 2024" also highlights the contribution of POC test devices to the overall diagnostics market growth. More diagnostic manufacturers are seeking CLIA waiver status or CE Mark for their POC devices, indicating the growing importance of POC testing in diagnosis and patient care monitoring. Rapid tests are also becoming more prevalent in the POC arena, allowing physicians to treat patients more effectively and efficiently.

This report breaks out point-of-care testing by segment.

Among the top and/or innovative competitors discussed within Corporate Profiles are:

Scope and Methodology

"The Worldwide Market for Point-of-Care (POC) Diagnostic Tests" is now in its eleventh edition, reflecting more than two decades of Kalorama's analysis of the POC market.

The geographic scope of "The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 2024" is global, with information for specific geographical regions, world demographics, and other general issues affecting the market. The report's market summary includes total market values, market analysis by product, test usage, technology, region, end-use and a competitive analysis of leading providers. Additionally, key company profiles are included.

All market data pertains to the world market at the manufacturers' level. The market includes manufacturer tests excluding services. The base year for data was 2023. Forecast data is provided for 2023 through 2028. Compound annual growth rates (CAGRs) are provided for the 2023-2028 period for each segment covered. Competitive analysis is provided for the year 2023 along with regional breakdowns. The forecasted market analysis for 2023-2028 was largely based on demographic trends, new developments, innovative technology and global expansion.

Table of Contents

Chapter 1: Executive Summary

• Introduction
• Scope and Methodology
• Size and Growth of the Market
  • Table 1-1: Global POC Test Market, 2023-2028 (in millions $ at manufacturer level)
• Trends Affecting the Market
• Competitive Outlook
• Market Conclusions
• Conclusion One - POC market transformed by technological progress
• Conclusion Two - POC Molecular Diagnostics continue making inroads
• Conclusion Three - Prevention and early detection at nexus of POC development
• Conclusion Four - Wearables continue to influence POC market
• Conclusion Four - Test cost will continue to be an issue worldwide
• Conclusion Five - Rising demand will drive POC market in RoW markets
• Conclusion Six - New venues - urgent & retail care
• Conclusion Seven - COVID-19's Positive Effect
• Conclusion Eight - Insurance coverage for OTC COVID-19 testing
• Conclusion Nine - New Opportunities in POC Infectious Disease Testing
• Conclusion Ten - Supply Chain Delays
• Conclusion Eleven - Multiplex Testing Explodes
• Conclusion Twelve - AI Making Inroads into POC
• Conclusion Thirteen - Stand-alone ER/Urgent Centers Gain Acceptance
• Conclusion Fourteen - Digital Diagnostics and POC
• Conclusion Fifteen - Microfluidics Gaining Ground in POC

Chapter 2: Introduction and Overview

• Point-of-Care Diagnostics Testing
• Industry Regulations
• Types of CLIA Certificates
• POC Industry Drivers
• Patient focused drivers
• Medical/Healthcare related drivers
• Technology drivers
• Economic drivers
• Other drivers
• POC Industry Challenges
• POC Test Types
• Blood
• Urine
• Saliva
• Hair
• Optical Technologies
• Breath
• Conditions Evaluated by POC Diagnostic Testing
• Cancer
  • Colorectal Cancer
  • Prostate Cancer
• Cardiovascular Disease
• Diabetes
• Drug Abuse
• Infectious Disease
  • Herpes
  • HTLV
  • Respiratory Syncytial Virus
  • Hepatitis
  • Lyme Disease
  • Babesiosis
  • Gonorrhea, Syphilis and Chlamydia
  • Trichomonas Vaginalis
  • HIV/AIDS
  • Helicobacter Pylori
  • Influenza
  • Coronavirus
  • Mononucleosis
  • Streptococcus
• Osteoporosis
• Pregnancy and Fertility

Chapter 3: POC Blood Glucose Tests

• Types of Blood Glucose Testing
• Fasting Blood Sugar (FBS)
• 2-Hour Postprandial Blood Sugar (PPBS)
• Random Blood Sugar
• Glucose Tolerance Test
• Glucose Urine Test
• Glycated Hemoglobin (HbA1c)
• Products
• Blood Glucose Self-Testing
  • Table 3-1: Selected Glucose Self-Test Meter Innovations
  • Table 3-2: Selected Apps and Glucose Management IT
• Continuous Self-Testing
• Glycated Hemoglobin Tests
  • Table 3-3: Selected POC HbA1c Devices
• Professional
• Market Size and Growth
  • Table 3-4: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
  • Table 3-5: Global POC Diabetes Sales, by Test Category, 2023-2028 (Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC; TOTAL; $ millions)
• Regional Analysis
  • Figure 3-1: POC Blood Glucose Testing Regional Market Analysis, 2023 (%)
• POC Glucose Self-Testing
  • Table 3-6: Global POC Glucose Self-Testing Market (excludes continuous glucose devices), 2023-2028 (in millions $ at manufacturer level)
  • POC Continuous Glucose Self-Testing
  • Table 3-7: Global POC Continuous Glucose Self-Testing Market, 2023-2028 (in millions $ at manufacturer level)
• POC Glucose Professional Testing
  • Table 3-8: Global POC Glucose Professional Testing Market (excludes HbA1c testing), 2023-2028 (in millions $ at manufacturer level)
  • POC HbA1c Testing
  • Table 3-9: Global POC Glucose HbA1c Professional Testing Market, 2023-2028 (in millions $ at manufacturer level)
• Competitive Analysis
  • Table 3-10: Global POC Blood Glucose Testing Market (BGM, CGM,HbA1c) Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 3-2: Global POC Glucose Test Manufacturers, by Percent, 2023 (%)

Chapter 4: POC Blood and Electrolytes Testing Market

• Types of Blood and Electrolytes Tests
• Hemoglobin/Hematocrit
• WBC and Other
• Blood Gases
• Electrolytes
• Products
  • Table 4-1: Selected POC Hemoglobin and Hematocrit Systems, 2023
  • Table 4-2: Selected POC Hematology Analyzer Systems, 2023
• Market Size and Growth
  • Table 4-3: Global POC Blood and Electrolytes Testing (Blood Gases/Electrolytes, Hemoglobin/Hematocrit, WBC), Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
  • Table 4-4: Global POC Blood & Electrolytes Revenues, by Test Category, 2023-2028 ($ millions)
• Regional Analysis
  • Figure 4-1: POC Blood and Electrolytes Testing Regional Market (US, Europe, Japan, Rest of World) Analysis, 2023 (%)
• POC Blood and Electrolyte Self-Testing
  • Table 4-5: Global POC Blood and Electrolyte Self Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• POC Blood and Electrolyte Professional Testing
  • Table 4-6: Global POC Blood and Electrolyte Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Competitive Analysis
  • Table 4-7: Global POC Blood and Electrolyte Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 4-2: Global POC Blood and Electrolyte Testing Market Manufacturers, by Percent, 2023 (%)

Chapter 5: POC Rapid Coagulation

• Products
  • Table 5-1: Selected POC Coagulation Test Innovations
• Platelet Testing
  • Table 5-2: Selected Platelet Activity Test Innovations
• Market Size and Growth
  • Table 5-3: Global Rapid Coagulation Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Regional Analysis
  • Figure 5-1: POC Rapid Coagulation Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
• POC Rapid Coagulation Self-Testing
  • Table 5-4: POC Rapid Coagulation Self-Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• POC Rapid Coagulation Professional Testing
  • Table 5-5: POC Rapid Coagulation Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Competitive Analysis
  • Table 5-6: Global POC Rapid Coagulation Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 5-2: Global POC Rapid Coagulation Testing Market, Market Share of Leading Suppliers, 2023 (%)

Chapter 6: POC Rapid Cardiac Markers

• Products
• Market Size and Growth
  • Table 6-1: Total Rapid Cardiac Markers Tests Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Regional Analysis
  • Figure 6-1: POC Rapid Cardiac Markers Testing, Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
• Competitive Analysis
  • Table 6-2: Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 6-2: Global POC Cardiac Markers Test Manufacturers, by Percent, 2023 (%)

Chapter 7: POC Substance Abuse

• Overview
• Products
• Urine
• Oral
• Blood
• Hair
• Market Size and Growth
  • Table 7-1: Global POC Drugs of Abuse Testing (critical care, employment and criminal) Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Regional Analysis
  • Figure 7-1: POC Substance Abuse Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
• POC Drugs of Abuse Self-Testing
  • Table 7-2: Global POC Drugs of Abuse Self Testing Market, 2023-2028 ($ millions at the manufacturer's level)
• POC Drugs of Abuse Professional Testing
  • Table 7-3: Global POC Drugs of Abuse Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Competitive Analysis
  • Table 7-4: Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 7-2: Global POC Drug of Abuse Testing Manufacturers, by Percent, 2023 (%)

Chapter 8: POC Pregnancy and Fertility Testing

• Products
  • Table 8-1: Selected Pregnancy and Fertility CLIA Waivers (Manufacturer and Instrument / Assay), Manufacturer's Instrument / Device / Assay
• Market Size and Growth
  • Table 8-2: Global POC Pregnancy and Fertility Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Regional Analysis
  • Figure 8-1: POC Pregnancy and Fertility Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
• POC Pregnancy and Fertility Self-Testing
  • Table 8-3: POC Pregnancy and Fertility Self-Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• POC Pregnancy and Fertility Professional Testing
  • Table 8-4: POC Pregnancy and Fertility Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Competitive Analysis
  • Table 8-5: Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 8-2 Global POC Pregnancy and Fertility Testing Manufacturers, by Percent, 2023 (%)

Chapter 9: POC Colon Cancer Screening/Fecal Occult Blood Testing

• Products
  • Table 9-1: Selected POC Colon Cancer Tests
• Market Size and Growth
  • Table 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Regional Analysis
  • Figure 9-1: POC Colon Cancer Screening/FOB Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
• POC Colon Cancer Screening/Fecal Occult Blood Self-Testing
  • Table 9-3: POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• POC Colon Cancer Screening/ Fecal Occult Blood Professional Testing
  • Table 9-4: POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Competitive Analysis
  • Table 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers, by Percent, 2023 (%)

Chapter 10: POC Infectious Disease Testing

• Products
• HIV and Hepatitis
• Respiratory
• STD/STI
• Tropical Diseases
• Lyme Disease
• TB
• Zika
• Anthrax
• Other Viruses
• Hospital Acquired Infections and Sepsis
  • Sepsis
  • Diff
    • Table 10-1: Selected Innovations in POC Infectious Disease Diagnostics
• COVID-19
  • Antigen
    • Table 10-2: Selected Antigen POC Home Immunoassay Tests for SARS-CoV-2
  • Serology
  • Molecular
    • Table 10-3: Selected Molecular POC Home Tests for SARS-CoV-2
• Market Size and Growth
  • Table 10-4: Global POC Infectious Disease (including COVID-19) Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Regional Analysis
  • Figure 10-1: POC Infectious Disease (including COVID-19) Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
• POC Infectious Disease Self-Testing
  • Table 10-5: POC Infectious Disease Self-Testing (including COVID-19) Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• POC Infectious Disease Professional Testing
  • Table 10-6: POC Infectious Disease (including COVID-19) Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• POC Infectious Disease Testing by Disease Type
  • Table 10-7: Global POC Infectious Disease Revenues and Percent of Infectious Disease Market, by Disease Type, 2023 (in millions $)
  • Figure 10-2: Global POC Infectious Disease (COVID-19, Influenza, HIV, STD, Hepatitis, Malaria, C. Diff, coli, H. pylori, Home, Others), Percent by Disease Type, 2023 (%)
• Competitive Analysis
  • Table 10-8: Global POC Infectious Disease including COVID-19 Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 10-3: Global POC Infectious Disease Test Manufacturers, by Percent, 2023 (%)

Chapter 11: POC Lipid Testing

• Products
• Market Size and Growth
  • Table 11-1: Global POC Lipid Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Regional Analysis
  • Figure 11-1: POC Lipid Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
• POC Lipid Self-Testing
  • Table 11-2: POC Lipid Self-Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• POC Lipid Professional Testing
  • Table 11-3: POC Lipid Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Competitive Analysis
  • Table 11-4: Global POC Lipid Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 11-2: Global POC Lipid Testing Manufacturers, by Percent, 2023 (%)

Chapter 12: POC Cancer Tumor Marker Testing

• Products
  • Table 12-1: Selected Companies Developing and/or Marketing POC Tests for Oncology Indications
• Market Size and Growth
  • Table 12-2: Global POC Cancer Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Regional Analysis
  • Figure 12-1: POC Cancer Tumor Marker Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
• Competitive Analysis
  • Table 12-3: Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 12-2: Global POC Cancer Testing Manufacturers, by Percent, 2023 (%)

Chapter 13: POC Urine Testing

• Products
• Market Size and Growth
  • Table 13-1: Global POC Urine Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Regional Analysis
  • Figure 13-1: POC Urine Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
• POC Urine Self-Testing
  • Table 13-2: POC Urine Self-Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• POC Urine Test Professional Testing
  • Table 13-3: POC Urine Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Competitive Analysis
  • Table 13-4: Global POC Urine Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 13-2: Global POC Urine Strip Testing Manufacturers, by Percent, 2023 (%)

Chapter 14: Miscellaneous POC Testing

• Microbiology
• TSH
• Allergy
• Autoimmune
• Others
• Market Size and Growth
  • Table 14-1: Global Miscellaneous POC Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
  • Table 14-2: Global POC Miscellaneous Sales, by Test Category, 2023-2028 (Microbiology, TSH, Allergy, Autoimmune, Others TOTAL; $ millions)
• Regional Analysis
  • Figure 14-1: POC Miscellaneous Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)

Chapter 15: Issues and Trends

• Overview
• Wearables
  • Table 15-1: Selected Wearable Devices
• Mobile Healthcare Technologies
• Telehealth
• Telehealth eMed to Implement Home Test to Treat Program
• Patient-centered Healthcare
• Breath Test Advances
  • Table 15-2: Selected Disease Markers in Exhaled Breath
• Regulatory Hurdles
• Reimbursement Challenges
• PAMA
• Competition
• POC and Molecular Diagnostics
  • Table 15-3: Selected Market Available Molecular POC Diagnostic Platforms
• POC Biosensors and Microfluidics
  • Table 15-4: Selected FDA-Approved Microfluidic-based POC Tests 2023
  • Table 15-5: Selected Biochip and Biosensor Players, 2023
• China as a POC Market
• Emerging POC Technologies
• POC Connectivity
• COVID-19 Impact
• Multiplexed POC Testing
  • Figure 15-1: Multiplexed POC Testing Schematic
• The Emergence of Non-invasive Technologies
• Saliva and Swab
• Optical Techniques
• Near-infrared Scanning
• Volatolomics
• POC and Antibiotic Resistance Concern
• Artificial Intelligence in POC
• POC Future in Infectious Disease Diagnostics
• Supply Chain Delays
• Insurance Coverage for OTC Diagnostic Tests
• Stand-Alone Emergency Department/Urgent Care Centers Combine with POC Team in New Mexico
• Digital Diagnostics
• Microfluidics and POC

Chapter 16: Total Global POC Testing Market and Competitor Analysis

• Market Overview
  • Table 16-1: Global POC Test Market, 2023-2028 (in millions $ at manufacturer level)
• Market Analysis by Product Categories
  • Table 16-2: Global POC Testing Market Analysis, by Product Category, 2023 (in millions $)
• Market Analysis by Subcategory
• POC Self-Testing
  • Table 16-3: Global POC Self-Testing Market Analysis, by Product Category, 2023 (in millions $)
  • Figure 16-1: Global POC Self-Testing Market Analysis, by Product Category, 2023 (%)
• POC Professional Testing
  • Table 16-4: Global POC Professional Testing Market Analysis, by Product Subcategory, 2023 (in millions $)
  • Figure 16-2 : Global POC Professional Testing Market Analysis, by Product Subcategory, 2023 (%)
• POC Testing by End-Use
  • Figure 16-3: POC Testing, by End-user, 2023
• Market by Device Technology
  • Figure 16-4: Global POC Market, by Technology, by Sales, 2023, (%)
• Market Analysis by Country
• United States
  • Table 16-5: US POC Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Europe
  • Table 16-6: Europe POC Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
  • Germany
  • France
  • UK
  • Switzerland and Sweden
  • Other
    • Figure 16-5: Europe POC Testing Percentage Participation, by Country, 2023 (%)
• Japan
  • Table 16-7: Japan POC Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Rest of World
  • Latin America
  • China
  • India
  • South Korea
  • Other RoW Countries
    • Table 16-8: Global POC Testing Market Analysis, by Rest of World Region/Country, 2023 (in millions $)
    • Figure 16-6: Global POC Testing Market Analysis, by Rest of World Region/Country, 2023 (%)
    • Table 16-9: Global POC Testing Analysis, by Region/Country, 2023 (in millions $)
    • Figure 16-7: Global POC Testing Market Analysis Percent, by Region/Country, 2023 (%)
• Competitive Analysis
  • Table 16-10: Global Top 10 POC Testing Market Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 16-8: Global POC Testing Market Share, by Leading Suppliers, 2023 (%)

Chapter 17: Corporate Profiles

• Overview

• 1 Step Detect Associates, LLC
  • Table 17-1: 1-Step Detect Associates Corporate Summary
• Company Overview
• Products

• Abbott Laboratories
  • Table 17-2: Abbott Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-3: Abbott Revenues 2020-2023 (in millions $)

• Abingdon Health Ltd.
  • Table 17-4: Abingdon Health Corporate Summary
• Company Overview
• Products
• COVID-19

• Access Bio, Inc.
  • Table 17-5: Access Bio Corporate Summary
• Company Overview
• Products
• COVID-19

• AccuBioTech Co, Ltd.
  • Table 17-6: AccuBioTech Corporate Summary
• Company Overview
• Products
• COVID-19

• ACON Laboratories, Inc
  • Table 17-7: ACON Laboratories Corporate Summary
• Company Overview
• Products
• COVID-19

• Aerscher Diagnostics, LLC
  • Table 17-8: Aerscher Diagnostics Corporate Summary
• Company Overview
• Products

• Alfa Scientific Designs, Inc
  • Table 17-9: Alfa Scientific Corporate Summary
• Company Overview
• Products
• COVID-19

• American Bio Medica Corporation
  • Table 17-10: American Bio Medica Corporate Summary
• Company Overview
• Products
• COVID-19

• ARKRAY, Inc.
  • Table 17-11: ARKRAY Corporate Summary
• Company Overview
• Products

• Artron Laboratories, Inc
  • Table 17-12: Artron Laboratories Corporate Summary
• Company Overview
• Products
• COVID-19

• Ascensia Diabetes Care Holdings AG
  • Table 17-13: Ascensia Diabetes Care Corporate Summary
• Company Overview
• Products

• Atlas Link Biotech Co., Ltd
  • Table 17-14: Atlas Link Biotech Corporate Summary
• Company Overview
• Products
• COVID-19

• Autobio Diagnostics Co., Ltd
  • Table 17-15: Autobio Diagnostics Corporate Summary
• Company Overview
• Products
• COVID-19

• Beckman Coulter, Inc
  • Table 17-16: Beckman Coulter Corporate Summary
• Company Overview
• Products
• COVID-19
• Company Financials
  • Table 17-17: Beckman Coulter Revenue, 2020-2023 ($ millions)

• Becton Dickinson (BD)
  • Table 17-18: BD Corporate Summary
• Company Overview
• Products
• COVID-19
• Company Financials
  • Table 17-19: BD Corporation Revenues, 2020-2023 ($ millions)

• Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  • Table 17-20: Beijing Wantai Biological Pharmacy Enterprise Corporate Summary
• Company Overview
• Products
• COVID-19

• Bhat Bio-Tech India Private Ltd. (BBI)
  • Table 17-21: Bhat Bio-Tech India Private Corporate Summary
• Company Overview
• Products
• COVID-19

• binx health
  • Table 17-22: binx health Corporate Summary
• Company Overview
• Products
• COVID-19

• bioLytical Laboratories
  • Table 17-23: bioLytical Laboratories Corporate Summary
• Company Overview
• Products
• COVID-19

• BioMedomics, Inc.
  • Table 17-24: BioMedomics Corporate Summary
• Company Overview
• Products
• COVID-19

• Biomeme, Inc.
  • Table 17-25: Biomeme Corporate Summary
• Company Overview
• Products

• Biomerica, Inc.
  • Table 17-26: Biomerica Corporate Summary
• Company Overview
• Products
• Company Financials
  • Table 17-27: Biomerica Corporation Revenues, 2020-2023 ($ millions)

• bioMerieux SA
  • Table 17-28: bioMerieux SA Corporate Summary
• Company Overview
• Products
• COVID-19
• Company Financials
  • Table 17-29: bioMerieux Revenues, 2020-2023 ($ millions)

• Bio-Rad Laboratories Inc.
  • Table 17-30: Bio-Rad Labs Corporate Summary
• Company Overview
• Products
• Company Financials
  • Table 17-31: Bio-Rad Corporation Revenues, 2020-2023 ($ millions)

• Biosynex SA
  • Table 17-32: Biosynex SA Corporate Summary
• Company Overview
• Products

• Biotron Diagnostics, Inc.
  • Table 17-33: Biotron Diagnostics Corporate Summary
• Company Overview
• Products

• Boditech Med Inc.
  • Table 17-34: Boditech Med Corporate Summary
• Company Overview
• Products
• COVID-19

• Boson Biotech Co. Ltd.
  • Table 17-35: Boson Biotech Corporate Summary
• Company Overview
• Products
• COVID-19

• BTNX Inc.
  • Table 17-36: BTNX Corporate Summary
• Company Overview
• Products
• COVID-19

• Cepheid, Inc.
  • Table 17-37: Cephid Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-38: Cepheid Revenues, 2020-2023 ($ millions)

• Chembio Diagnostics Systems, Inc.
  • Table 17-39: Chembio Diagnostic Corporate Summary
• Company Overview
• Products
• COVID-19

• Church & Dwight Co. Inc.
  • Table 17-40: Church & Dwight Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-41: Church and Dwight Revenues, 2020-2023 ($ millions)

• Clarity Diagnostics, LLC
  • Table 17-42: Clarity Diagnostics Corporate Summary
• Company Overview
• Products
• COVID-19

• Confirm Biosciences
  • Table 17-43: Confirm Biosciences Corporate Summary
• Company Overview
• Products
• COVID-19

• CTK Biotech, Inc.
  • Table 17-44: CTK Biotech Corporate Summary
• Company Overview
• Products
• COVID-19

• Cue Health
  • Table 17-45: Cue Health Corporate Summary
• Company Overview
• Products
• COVID-19

• Danaher Corporation
  • Table 17-46: Danaher Corporation Summary
• Company Overview
• Products

• Dexcom, Inc.
  • Table 17-47: Dexcom Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-48: Dexcom Revenues, 2020-2023 ($ millions)

• DIALAB GmbH
  • Table 17-49: DIALAB Corporate Summary
• Company Overview
• Products
• COVID-19

• DiaSys Diagnostic Systems GmbH (Mindray)
  • Table 17-50: DiaSys Diagnostic Systems Corporate Summary
• Company Overview
• Products
• COVID-19

• Diazyme Laboratories, Inc.
  • Table 17-51: Diazyme Laboratories Corporate Summary
• Company Overview
• Products
• COVID-19

• DNA Electronics Ltd. (DNAe)
  • Table 17-52: DNA Electronics Corporate Summary
• Company Overview
• Products

• Dr. Fooke-Achterrath Laboratorien GmbH
  • Table 17-53: Dr. Fooke-Achterrath Laboratorien Corporate Summary
• Company Overview
• Products
• COVID-19

• DxGen Corp.
  • Table 17-54: DxGen Corporate Summary
• Company Overview
• Products
• COVID-19

• Eiken Chemical Co. Ltd.
  • Table 17-55: Eiken Chemical Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-56: Eiken Chemical Revenues, 2020-2023 ($ millions)

• EKF Diagnostics Holdings plc
  • Table 17-57: EKF Diagnostics Corporate Summary
• Company Overview
• Products

• ELITechGroup S.A.S.
  • Table 17-58: ELITechGroup Corporate Summary
• Company Overview
• Products
• COVID-19

• Eurobio Scientific
  • Table 17-59: Eurobio Scientific Corporate Summary
• Company Overview
• Products
• COVID-19

• Everlywell
  • Table 17-60: Everlywell Corporate Summary
• Company Overview
• Products
• COVID-19

• Exact Sciences
  • Table 17-61: Exact Sciences Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-62: Exact Sciences Revenues, 2020-2023 ($ millions)

• EY Laboratories
  • Table 17-63: EY Laboratories Corporate Summary
• Company Overview
• Products

• First Check Diagnostics LLC
  • Table 17-64: First Check Diagnostics Corporate Summary
• Company Overview
• Products

• GenBio
  • Table 17-65: GenBio Corporate Summary
• Company Overview
• Products

• Genedrive plc
  • Table 17-66: Genedrive Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-67: Genedrive Revenues, 2020-2023 ($ millions)

• GeTein Biotech Inc.
  • Table 17-68: GeTein Corporate Summary
• Company Overview
• Products
• COVID-19

• Helena Laboratories
  • Table 17-69: Helena Laboratories Corporate Summary
• Company Overview
• Products

• Hemosure, Inc. (W.H.P.M)
  • Table 17-70: Hemosure Corporate Summary
• Company Overview
• Products

• HORIBA, Ltd.
  • Table 17-71: HORIBA Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-72: HORIBA Revenues, 2020-2023 ($ millions)

• Immune IQ
  • Table 17-73: Immune IQ Corporate Summary
• Company Overview
• Products

• Immunosciences Lab, Inc.
  • Table 17-74: Immunosciences Lab Corporate Summary
• Company Overview
• Products

• Immunostics, Inc.
  • Table 17-75: Immunostics Corporate Summary
• Company Overview
• Products
• COVID-19

• JAL Innovation PTE LTD.
  • Table 17-76: JAL Innovation Corporate Summary
• Company Overview
• Products

• Jant Pharmacal Corporation
  • Table 17-77: Jant Pharmacal Corporate Summary
• Company Overview
• Products

• 1.Mitra & Co Pvt. Ltd.
  • Table 17-78: J Mitra Corporate Summary
• Company Overview
• Products
• Covid-19

• Kypha
  • Table 17-79: Kypha Corporate Summary
• Company Overview
• Products

• LamdaGen Corporation
  • Table 17-80: LamdaGen Corporate Summary
• Company Overview
• Products
• COVID-19

• LifeScan, Inc.
  • Table 17-81: LifeScan Corporate Summary
• Company Overview
• Products

• LifeSign, LLC
  • Table 17-82: LifeSign Corporate Summary
• Company Overview
• Products
• COVID-19

• LightDeck Diagnostics
  • Table 17-83: LightDeck Diagnostics Corporate Summary
• Company Overview
• Products
• COVID-19

• LumiraDx UK Limited
  • Table 17-84: LumiraDx Corporate Summary
• Company Overview
• Products

• Macherey-Nagel GmbH & Co. KG
  • Table 17-85: Macherey-Nagel Corporate Summary
• Company Overview
• Products

• Medix Biochemica
  • Table 17-86: Medix Biochemica Corporate Summary
• Company Overview
• Products
• COVID-19

• MedMira, Inc.
  • Table 17-87: MedMira Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-88: MedMira Revenues, 2020-2023 ($ thousands)

• Medtronic, Inc.
  • Table 17-89: Medtronic Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-90: Medtronic Revenues, 2020-2023 ($ millions)

• 1.Menarini Diagnostics srl.
  • Table 17-91: Menarini Diagnostics Corporate Summary
• Company Overview
• Products
• COVID-19

• Meridian Bioscience, Inc.
  • Table 17-92: Meridian Bioscience Corporate Summary
• Company Overview
• Products
• COVID-19

• MiCo BioMed
  • Table 17-93: MiCo BioMed Summary
• Company Overview
• Products

• Nano-Ditech Corporation
  • Table 17-94: Nano-Ditech Corporate Summary
• Company Overview
• Products
• COVID-19

• Nexus Dx Inc.
  • Table 17-95: Nexus Dx Corporate Summary
• Company Overview
• Products

• NG Biotech
  • Table 17-96: NG Biotech Corporate Summary
• Company Overview
• Products
• COVID-19

• Noble Medical, Inc.
  • Table 17-97: Noble Medical Corporate Summary
• Company Overview
• Products

• Nova Biomedical Corp.
  • Table 17-98: Nova Biomedical Corporate Summary
• Company Overview
• Products

• Oasis Diagnostics Corporation
  • Table 17-99: Oasis Diagnostics Corporate Summary
• Company Overview
• Products

• Operon S.A.
  • Table 17-100: Operon Corporate Summary
• Company Overview
• Products
• COVID-19

• OPKO Health, Inc.
  • Table 17-101: OPKO Health Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-102: OPKO Health Revenues, 2020-2023 ($ millions)

• OraSure Technologies, Inc.
  • Table 17-103: OraSure Technologies Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-104: OraSure Revenues, 2020-2023 ($ millions)

• PixCell Medical Technologies
  • Table 17-105: PixCell Corporate Summary
• Company Overview
• Products

• Polymedco, Inc.
  • Table 17-106: Polymedco Corporate Summary
• Company Overview
• Products

• Polymer Technologies, Inc. (PTS Diagnostics)
  • Table 17-107: Polymer Technologies Corporate Summary
• Company Overview
• Products
• COVID-19

• Preventis GmbH
  • Table 17-108: Preventis Corporate Summary
• Company Overview
• Products

• Princeton Biomeditech Corporation
  • Table 17-109: Princeton Biomeditech Corporate Summary
• Company Overview
• Products
• Covid-19

• QuantuMDx Group Limited
  • Table 17-110: QuantuMDx Group Corporate Summary
• Company Overview
• Products
• COVID-19

• QuidelOrtho Corporation
  • Table 17-111: QuidelOrtho Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-112: QuidelOrtho Revenues, 2020-2023 ($ millions)

• Radiometer Medical A/S
  • Table 17-113: Radiometer Medical Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-114: Radiometer, 2020-2023 ($ millions)

• Randox Laboratories Limited
  • Table 17-115: Randox Labs Corporate Summary
• Company Overview
• Products
• COVID-19

• Response Biomedical Corp.
  • Table 17-116: Response Biomedical Corporate Summary
• Company Overview
• Products
• COVID-19

• Reszon Diagnostics International Sdn. Bhd.
  • Table 17-117: Reszon Diagnostics Corporate Summary
• Company Overview
• Products
• COVID-19

• Rheonix, Inc.
  • Table 17-118: Rheonix Corporate Summary
• Company Overview
• Products
• COVID-19

• Roche Diagnostic Corporation
  • Table 17-119: Roche Diagnostic Corporate Summary
• Company Overview
• Products
  • Table 17-120: Roche POC Marketed Products
• COVID-19
• Performance Review
  • Table 17-121: Roche Diagnostics, 2020-2023 ($ millions)

• Savyon Diagnostics
  • Table 17-122: Savyon Diagnostics Corporate Summary
• Company Overview
• Products
• COVID-19

• Sekisui Diagnostics LLC
  • Table 17-123: Sekisui Diagnostics Corporate Summary
• Company Overview
• Products
• COVID-19

• Siemens Healthineers GmbH
  • Table 17-124: Siemens Healthineers Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-125: Siemens Healthineers, 2020-2023 ($ millions)

• Sysmex Corporation
  • Table 17-126: Sysmex Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-127: Sysmex, 2020-2023 ($ millions)

• TECHLAB, Inc.
  • Table 17-128: TECHLAB Corporate Summary
• Company Overview
• Products

• Trinity Biotech PLC
  • Table 17-129: Trinity Biotech Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-130: Trinity Biotech Revenues, 2020-2023 ($ millions)

• Trividia Health
  • Table 17-131: Trividia Health Corporate Summary
• Company Overview
• Products

• Tulip Diagnostics Ltd. (Tulip Group)
  • Table 17-132: Tulip Diagnostics Corporate Summary
• Company Overview
• Product
• COVID-19

• VedaLab
  • Table 17-133: VedaLab Corporate Summary
• Company Overview
• Products
• COVID-19

• Werfen
  • Table 17-136: Werfen Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-137: Werfen, 2020-2023 ($ millions)